Winton Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-131,178
Closed -$708K 1190
2026
Q1
$708K Buy
131,178
+82,321
+168% +$493K 0.02% 622
2025
Q4
$340K Buy
48,857
+871
+2% +$5.73K 0.01% 718
2025
Q3
$310K Buy
+47,986
New +$328K 0.01% 625
2023
Q1
Sell
-101,951
Closed -$640K 962
2022
Q4
$640K Buy
+101,951
New +$712K 0.04% 560
2022
Q3
Sell
-31,647
Closed -$265K 950
2022
Q2
$265K Buy
+31,647
New +$442K 0.01% 830

Other funds holding BHC

Winton Group's BHC Position: Q2 2026 in Review

Winton Group sold out of Bausch Health (BHC) in Q2 2026, closing a stake of 131,178 shares — an estimated $708K sold.

Winton Group first reported a position in BHC in Q2 2022 and held it in 5 quarters. The position peaked at $708K in Q1 2026. 161 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Winton Group reported no remaining Bausch Health position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 131,178 Bausch Health shares in Q2 2026, an estimated $708K.
  • Winton Group first reported a position in Bausch Health in Q2 2022 and held it in 5 quarters.
  • Winton Group's Bausch Health position peaked at $708K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.